Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Eli Lilly stock rose Thursday despite lighter-than-expected sales of its weight-loss and diabetes drugs Zepbound and Mounjaro.

After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...

Eli Lilly and Company LLY reported fourth-quarter 2024 adjusted earnings per share (“EPS”) of $5.32, which beat the Zacks ...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their ...

A international tourist to South Korea's southernmost resort island of Jeju has tested positive for measles, making the first ...

The Danish pharma group reported sales growth of 33% in the first nine months of the year to DKK ... becoming sought after for their weight-loss properties. In some countries, there are reports ...

Lilly, meanwhile, has been selling its GLP-1 agonist Trulicity (dulaglutide ... so it is a key target for all drugmakers with weight-loss products. Some estimates predict the number of overweight ...

Anne-Marie Zanzal, 60, and her wife Tonda McKay, 62, have also experienced the more positive changes that weight-loss drugs ...

Aimee Meier, a fat loss and hormone health coach, has successfully lost 31 kg in 9 months while managing PCOS and raising five children. She recently shared her top three weight loss tips with her ...